• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎的“副作用”:关节破坏、残疾和过早死亡。

The 'side effects' of rheumatoid arthritis: joint destruction, disability and early mortality.

作者信息

Pincus T, Callahan L F

机构信息

Vanderbilt University School of Medicine, Department of Medicine, Nashville, TN 37232.

出版信息

Br J Rheumatol. 1993 Mar;32 Suppl 1:28-37.

PMID:8448634
Abstract

Most patients with RA experience disease progression over periods longer than 5 years, characterized by radiographic joint destruction, declines in functional capacity to perform activities of daily living, frequent work disability, high levels of co-morbidities, and death earlier than expected. These long-term consequences of RA may be viewed as 'side effects' of disease, which must be balanced against possible side effects of drugs in planning treatments of patients with RA. Aggressive approaches, which may include acceptance of mild and even moderate side effects of drugs, may be appropriate in efforts to prevent 'side effects' of RA.

摘要

大多数类风湿关节炎(RA)患者在超过5年的时间里会经历疾病进展,其特征为影像学上的关节破坏、日常生活活动功能能力下降、频繁的工作残疾、高共病率以及比预期更早的死亡。RA的这些长期后果可被视为疾病的“副作用”,在规划RA患者的治疗时,必须将其与药物可能的副作用进行权衡。积极的治疗方法,可能包括接受药物的轻度甚至中度副作用,在努力预防RA的“副作用”方面可能是合适的。

相似文献

1
The 'side effects' of rheumatoid arthritis: joint destruction, disability and early mortality.类风湿关节炎的“副作用”:关节破坏、残疾和过早死亡。
Br J Rheumatol. 1993 Mar;32 Suppl 1:28-37.
2
Resorptive arthropathy in rheumatoid arthritis.类风湿关节炎中的吸收性关节病
J Rheumatol. 1988 Jul;15(7):1075-7.
3
A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.对类风湿性关节炎患者进行的1986 - 1996年10年前瞻性随访。
J Rheumatol. 2001 Nov;28(11):2409-15.
4
Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?类风湿关节炎临床缓解患者的关节损伤进展:生物制剂比合成抗风湿药物效果更好吗?
J Rheumatol. 2014 Aug;41(8):1576-82. doi: 10.3899/jrheum.130767. Epub 2014 Jul 15.
5
The underestimated long term medical and economic consequences of rheumatoid arthritis.类风湿关节炎被低估的长期医学和经济后果。
Drugs. 1995;50 Suppl 1:1-14. doi: 10.2165/00003495-199500501-00003.
6
A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis.高体重指数对早期类风湿关节炎小关节的关节破坏量具有保护作用。
Ann Rheum Dis. 2008 Jun;67(6):769-74. doi: 10.1136/ard.2007.078832. Epub 2007 Oct 26.
7
Rheumatoid arthritis: understanding joint damage and physical disability in RA.类风湿关节炎:了解类风湿关节炎中的关节损伤和身体残疾
Nat Rev Rheumatol. 2011 May;7(5):260-1. doi: 10.1038/nrrheum.2011.49.
8
Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis.类风湿关节炎患者接受肌肉注射甲氨蝶呤治疗期间的放射学进展
J Rheumatol. 1990 Dec;17(12):1636-41.
9
Prevention of joint destruction in antigen-induced arthritis.抗原诱导性关节炎中关节破坏的预防
Clin Immunol Immunopathol. 1994 Jan;70(1):19-21. doi: 10.1006/clin.1994.1004.
10
Rheumatoid arthritis: pathogenesis and early recognition.类风湿关节炎:发病机制与早期识别
Am J Med. 1996 Feb 26;100(2A):3S-9S. doi: 10.1016/s0002-9343(97)89540-x.

引用本文的文献

1
Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals.多种自身抗体联合检测在预测高危人群向炎性关节炎进展中的价值。
RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002512.
2
Differential CpG DNA methylation in peripheral naïve CD4 T-cells in early rheumatoid arthritis patients.早期类风湿关节炎患者外周幼稚 CD4 T 细胞中的差异 CpG DNA 甲基化。
Clin Epigenetics. 2020 Apr 7;12(1):54. doi: 10.1186/s13148-020-00837-1.
3
Patellar tendon properties and lower limb function in rheumatoid arthritis and ankylosing spondylitis versus healthy controls: a cross-sectional study.
类风湿关节炎和强直性脊柱炎与健康对照者的髌腱特性及下肢功能:一项横断面研究
ScientificWorldJournal. 2013 Jun 5;2013:514743. doi: 10.1155/2013/514743. Print 2013.
4
Differences in activity limitation, pain intensity, and global health in patients with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up.瑞典和美国类风湿关节炎患者活动受限、疼痛强度和总体健康状况的差异:5 年随访。
Scand J Rheumatol. 2011 Nov;40(6):428-32. doi: 10.3109/03009742.2011.594963. Epub 2011 Sep 21.
5
Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate.在接受利妥昔单抗联合甲氨蝶呤治疗的类风湿关节炎患者中,2 年内持续抑制结构损伤。
Ann Rheum Dis. 2010 Jun;69(6):1158-61. doi: 10.1136/ard.2009.119222. Epub 2010 May 3.
6
Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group.阿达木单抗对类风湿关节炎患者工作参与度的影响:一项开放标签扩展研究与基于注册登记的对照组的比较
Ann Rheum Dis. 2009 Jun;68(6):930-7. doi: 10.1136/ard.2008.092734. Epub 2008 Oct 1.
7
Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs.类风湿关节炎的治疗:抗风湿药物使用的全球视角
Mod Rheumatol. 2008;18(3):228-39. doi: 10.1007/s10165-008-0056-x. Epub 2008 Apr 25.
8
Economic evaluations in rheumatoid arthritis: a critical review of measures used to define health States.类风湿关节炎的经济学评估:对用于定义健康状态的指标的批判性综述
Pharmacoeconomics. 2008;26(5):395-408. doi: 10.2165/00019053-200826050-00004.
9
Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial.影像学损伤程度和影像学进展是身体功能的决定因素:TEMPO试验的纵向分析。
Ann Rheum Dis. 2008 Sep;67(9):1267-70. doi: 10.1136/ard.2007.081331. Epub 2008 Jan 18.
10
Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison.在已接受柳氮磺胺吡啶治疗的活动性类风湿关节炎患者中,依那西普与柳氮磺胺吡啶单独及联合使用的双盲比较
Ann Rheum Dis. 2006 Oct;65(10):1357-62. doi: 10.1136/ard.2005.049650. Epub 2006 Apr 10.